PremiumThe FlyAllarity announces first patient enrolled in Phase 2 trial of stenoparib Allarity Therapeutics CEO to Present at Pharma Summit Allarity presents poster on new data on DRP for daratumumab PremiumThe FlyAllarity announces presentation from Phase 2 trial with stenoparib monotherapy Allarity announces final settlement with SEC including $2.5M civil penalty Allarity sees cash runway into 2026 PremiumThe FlyAllarity announces dismissal of securities class action lawsuit Allarity to begin enrollments for Phase 2 protocol to advance stenoparib Allarity announces expansion of Phase 2 trial on stenoparib